Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""HLA-DR"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 6782
Tytuł:
Renal graft function in transplanted patients correlates with CD45RC T cell phenotypic signature.
Autorzy:
Bézie S; Center for Research in Transplantation and Translational Immunology, Nantes Université, INSERM, UMR 1064, F-44000, Nantes, France.
Sérazin C; Center for Research in Transplantation and Translational Immunology, Nantes Université, INSERM, UMR 1064, F-44000, Nantes, France.
Autrusseau E; Center for Research in Transplantation and Translational Immunology, Nantes Université, INSERM, UMR 1064, F-44000, Nantes, France.
Vimond N; Center for Research in Transplantation and Translational Immunology, Nantes Université, INSERM, UMR 1064, F-44000, Nantes, France.
Giral M; Center for Research in Transplantation and Translational Immunology, Nantes Université, INSERM, UMR 1064, F-44000, Nantes, France.; Department of Nephrology, CHU Nantes, Nantes Université, ITUN, Nantes, France.
Anegon I; Center for Research in Transplantation and Translational Immunology, Nantes Université, INSERM, UMR 1064, F-44000, Nantes, France.
Guillonneau C; Center for Research in Transplantation and Translational Immunology, Nantes Université, INSERM, UMR 1064, F-44000, Nantes, France.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 21; Vol. 19 (3), pp. e0300032. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
CD8-Positive T-Lymphocytes*
HLA-DR Antigens*
Humans ; Reproducibility of Results ; Leukocyte Common Antigens/metabolism ; Graft Rejection ; Protein Tyrosine Phosphatases ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population.
Autorzy:
Zhao Y; Department of Infectious Diseases, Second Affiliated Hospital of Shandong First Medical University, 706 Taishan Street, Tai'an, Shandong Province, China.
Chen K; School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, 6699 Qingdao Road, Jinan, Shandong Province, China.
Yang H; School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, 6699 Qingdao Road, Jinan, Shandong Province, China.
Zhang F; Department of Gastrointestinal Surgery, Tai'an Central Hospital, 29 Longtan Road, Tai'an, Shandong Province, China.
Ding L; Department of Public Health, Jinan Central Hospital, 105 Jiefang Road, Jinan, Shandong Province, China.
Liu Y; School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, 6699 Qingdao Road, Jinan, Shandong Province, China.
Zhang L; School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, 6699 Qingdao Road, Jinan, Shandong Province, China.
Zhang Y; School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, 6699 Qingdao Road, Jinan, Shandong Province, China.
Wang H; Department of Infectious Diseases, Second Affiliated Hospital of Shandong First Medical University, 706 Taishan Street, Tai'an, Shandong Province, China.
Deng Y; School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, 6699 Qingdao Road, Jinan, Shandong Province, China. .
Pokaż więcej
Źródło:
Virology journal [Virol J] 2023 Nov 30; Vol. 20 (1), pp. 283. Date of Electronic Publication: 2023 Nov 30.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/virology
Hepatitis B virus*/genetics
Hepatitis B, Chronic*/genetics
Hepatitis B, Chronic*/virology
HLA-DR Antigens*/genetics
Liver Neoplasms*/genetics
Liver Neoplasms*/virology
Humans ; East Asian People ; Genetic Predisposition to Disease ; Genotype ; Mutation ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Intraoperative cell salvage: The impact on immune cell numbers.
Autorzy:
Roets M; Department of Anaesthesia, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
Sturgess D; Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.; Department of Anaesthesia, Surgical Treatment and Rehabilitation Service, Brisbane, Queensland, Australia.
Tran T; Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.
Obeysekera M; Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.
Perros A; Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.
Tung JP; Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.; Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.; Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia.
Flower R; Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.
van Zundert A; Department of Anaesthesia, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.; Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia.
Dean M; Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.; Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.; School of Health, University of the Sunshine Coast, Sunshine Coast, Queensland, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Aug 01; Vol. 18 (8), pp. e0289177. Date of Electronic Publication: 2023 Aug 01 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Interleukin-3 Receptor alpha Subunit*
HLA-DR Antigens*
Humans ; T-Lymphocytes, Regulatory ; Blood Transfusion ; Cell Count ; Dendritic Cells
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Gene association analysis to determine the causal relationship between immune cells and juvenile idiopathic arthritis.
Autorzy:
Chen L; The Third Affiliated Hospital of Zhejiang Chinese Medical University (Zhongshan Hospital of Zhejiang Province), Zhejiang, Hangzhou, China.; The Third School of Clinical Medicine (School of Rehabilitation Medicine), Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.; Research Institute of Tuina (Spinal disease), Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.
Zhou X; The Third Affiliated Hospital of Zhejiang Chinese Medical University (Zhongshan Hospital of Zhejiang Province), Zhejiang, Hangzhou, China.; The Third School of Clinical Medicine (School of Rehabilitation Medicine), Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.
Yang C; The Third Affiliated Hospital of Zhejiang Chinese Medical University (Zhongshan Hospital of Zhejiang Province), Zhejiang, Hangzhou, China.
Wu HJ; Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine), Zhejiang, Hangzhou, China.
Tian Y; The Third Affiliated Hospital of Zhejiang Chinese Medical University (Zhongshan Hospital of Zhejiang Province), Zhejiang, Hangzhou, China.; The Third School of Clinical Medicine (School of Rehabilitation Medicine), Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.
Hong S; The Third Affiliated Hospital of Zhejiang Chinese Medical University (Zhongshan Hospital of Zhejiang Province), Zhejiang, Hangzhou, China.; The Third School of Clinical Medicine (School of Rehabilitation Medicine), Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.
Hu H; The Third Affiliated Hospital of Zhejiang Chinese Medical University (Zhongshan Hospital of Zhejiang Province), Zhejiang, Hangzhou, China.; The Third School of Clinical Medicine (School of Rehabilitation Medicine), Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.
Wang K; The Third Affiliated Hospital of Zhejiang Chinese Medical University (Zhongshan Hospital of Zhejiang Province), Zhejiang, Hangzhou, China.; The Third School of Clinical Medicine (School of Rehabilitation Medicine), Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.
Wu S; The Third Affiliated Hospital of Zhejiang Chinese Medical University (Zhongshan Hospital of Zhejiang Province), Zhejiang, Hangzhou, China.; The Third School of Clinical Medicine (School of Rehabilitation Medicine), Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.
Wei Z; The Third Affiliated Hospital of Zhejiang Chinese Medical University (Zhongshan Hospital of Zhejiang Province), Zhejiang, Hangzhou, China.; The Third School of Clinical Medicine (School of Rehabilitation Medicine), Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.
Li T; The Third Affiliated Hospital of Zhejiang Chinese Medical University (Zhongshan Hospital of Zhejiang Province), Zhejiang, Hangzhou, China.; The Third School of Clinical Medicine (School of Rehabilitation Medicine), Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.
Huang Y; The Third Affiliated Hospital of Zhejiang Chinese Medical University (Zhongshan Hospital of Zhejiang Province), Zhejiang, Hangzhou, China.; The Third School of Clinical Medicine (School of Rehabilitation Medicine), Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.
Hua Z; The Third Affiliated Hospital of Zhejiang Chinese Medical University (Zhongshan Hospital of Zhejiang Province), Zhejiang, Hangzhou, China.; The Third School of Clinical Medicine (School of Rehabilitation Medicine), Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.
Xia Q; The Third Affiliated Hospital of Zhejiang Chinese Medical University (Zhongshan Hospital of Zhejiang Province), Zhejiang, Hangzhou, China.; The Third School of Clinical Medicine (School of Rehabilitation Medicine), Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.
Chen XJ; The 72nd Group Army Hospital of Chinese People's Liberation Army, Zhejiang, Huzhou, China.
Lv Z; The Third Affiliated Hospital of Zhejiang Chinese Medical University (Zhongshan Hospital of Zhejiang Province), Zhejiang, Hangzhou, China. .; The Third School of Clinical Medicine (School of Rehabilitation Medicine), Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China. .; Research Institute of Tuina (Spinal disease), Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China. .
Lv L; The Third Affiliated Hospital of Zhejiang Chinese Medical University (Zhongshan Hospital of Zhejiang Province), Zhejiang, Hangzhou, China. .; The Third School of Clinical Medicine (School of Rehabilitation Medicine), Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China. .; Research Institute of Tuina (Spinal disease), Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China. .
Pokaż więcej
Źródło:
Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2024 Mar 08; Vol. 22 (1), pp. 35. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Arthritis, Juvenile*/genetics
Humans ; Child ; Genotype ; Genetic Predisposition to Disease ; Reproducibility of Results ; HLA-DR Antigens/genetics ; Polymorphism, Single Nucleotide ; Genome-Wide Association Study
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Single Cell High Dimensional Analysis of Human Peripheral Blood Mononuclear Cells Reveals Unique Intermediate Monocyte Subsets Associated with Sex Differences in Coronary Artery Disease.
Autorzy:
Chatterjee N; La Jolla Institute of Immunology, La Jolla, CA 92037, USA.
Komaravolu RK; Department of Medicine, Immunology Center of Georgia, Augusta University, Augusta, GA 30912, USA.
Durant CP; La Jolla Institute of Immunology, La Jolla, CA 92037, USA.
Wu R; La Jolla Institute of Immunology, La Jolla, CA 92037, USA.
McSkimming C; Beirne Carter Immunology Center, University of Virginia, Charlottesville, VA 22904, USA.
Drago F; Beirne Carter Immunology Center, University of Virginia, Charlottesville, VA 22904, USA.
Kumar S; Department of Medicine, Immunology Center of Georgia, Augusta University, Augusta, GA 30912, USA.
Valentin-Guillama G; Department of Medicine, Immunology Center of Georgia, Augusta University, Augusta, GA 30912, USA.
Miller YI; Division of Endocrinology, University of California San Diego, La Jolla, CA 92093, USA.
McNamara CA; Beirne Carter Immunology Center, University of Virginia, Charlottesville, VA 22904, USA.
Ley K; La Jolla Institute of Immunology, La Jolla, CA 92037, USA.; Department of Medicine, Immunology Center of Georgia, Augusta University, Augusta, GA 30912, USA.
Taylor A; Beirne Carter Immunology Center, University of Virginia, Charlottesville, VA 22904, USA.
Alimadadi A; La Jolla Institute of Immunology, La Jolla, CA 92037, USA.; Department of Medicine, Immunology Center of Georgia, Augusta University, Augusta, GA 30912, USA.
Hedrick CC; La Jolla Institute of Immunology, La Jolla, CA 92037, USA.; Department of Medicine, Immunology Center of Georgia, Augusta University, Augusta, GA 30912, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 01; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Coronary Artery Disease*/metabolism
Humans ; Female ; Male ; Monocytes/metabolism ; Leukocytes, Mononuclear ; Sex Characteristics ; HLA-DR Antigens/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effect of cryopreservation on CD4+ T cell subsets in foreskin tissue.
Autorzy:
Almomani O; Department of Microbiology and Immunology, Western University, London, Canada.
Nnamutete J; Rakai Health Sciences Program, Kalisizo, Uganda.
Shao Z; Department of Microbiology and Immunology, Western University, London, Canada.
Biribawa VM; UVRI-IAVI HIV Vaccine Program Limited, Entebbe, Uganda.
Ssemunywa H; UVRI-IAVI HIV Vaccine Program Limited, Entebbe, Uganda.
Namuniina A; UVRI-IAVI HIV Vaccine Program Limited, Entebbe, Uganda.
Okech B; UVRI-IAVI HIV Vaccine Program Limited, Entebbe, Uganda.
Ulanova S; Department of Microbiology and Immunology, Western University, London, Canada.
Zuanazzi D; Department of Microbiology and Immunology, Western University, London, Canada.
Liu CM; Department of Environmental and Occupational Health, Milken Institute School of Public Health, George Washington University, Washington, DC, United States of America.
Tobian AAR; Department of Pathology, Johns Hopkins University School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
Galiwango RM; Rakai Health Sciences Program, Kalisizo, Uganda.
Kaul R; Departments of Medicine and Immunology, University of Toronto, Toronto, Canada.; University Health Network, Toronto, Canada.
Prodger JL; Department of Microbiology and Immunology, Western University, London, Canada.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 01; Vol. 19 (3), pp. e0297884. Date of Electronic Publication: 2024 Mar 01 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Foreskin*
HIV Infections*
Humans ; Male ; CD4-Positive T-Lymphocytes ; T-Lymphocyte Subsets ; Cryopreservation ; HLA-DR Antigens
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comprehensive Co-Inhibitory Receptor (Co-IR) Expression on T Cells and Soluble Proteins in Rheumatoid Arthritis.
Autorzy:
Wang CM; Department of Rehabilitation, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan 33302, Taiwan.
Jan Wu YJ; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, No. 5, Fu-Shin St. Kwei-Shan, Taoyuan 33305, Taiwan.
Huang LY; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, No. 5, Fu-Shin St. Kwei-Shan, Taoyuan 33305, Taiwan.
Zheng JW; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, No. 5, Fu-Shin St. Kwei-Shan, Taoyuan 33305, Taiwan.
Chen JY; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, No. 5, Fu-Shin St. Kwei-Shan, Taoyuan 33305, Taiwan.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Feb 26; Vol. 13 (5). Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:
Journal Article
MeSH Terms:
Programmed Cell Death 1 Receptor*
Arthritis, Rheumatoid*/pathology
Humans ; C-Reactive Protein/metabolism ; Hepatitis A Virus Cellular Receptor 2 ; HLA-DR Antigens ; Receptors, Immunologic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hyperactivation and enhanced cytotoxicity of reduced CD8 gamma delta T cells in the intestine of patients with Crohn's disease correlates with disease activity.
Autorzy:
Zhu T; Department of Pathology, Sir Run Run Shaw Hospital Affiliated with Zhejiang University School of Medicine, Hangzhou, 310000, China.
Zhu L; Department of Gastroenterology, Sir Run Run Shaw Hospital Affiliated with Zhejiang University School of Medicine, Hangzhou, 310000, China.
Sheng C; Department of Pathology, Sir Run Run Shaw Hospital Affiliated with Zhejiang University School of Medicine, Hangzhou, 310000, China.
Wu D; Department of Pathology, Sir Run Run Shaw Hospital Affiliated with Zhejiang University School of Medicine, Hangzhou, 310000, China.
Gu Q; Department of Pathology, Sir Run Run Shaw Hospital Affiliated with Zhejiang University School of Medicine, Hangzhou, 310000, China.
Jiang Z; Department of Pathology, Sir Run Run Shaw Hospital Affiliated with Zhejiang University School of Medicine, Hangzhou, 310000, China.
Xu J; Department of Pathology, Sir Run Run Shaw Hospital Affiliated with Zhejiang University School of Medicine, Hangzhou, 310000, China.
Fu G; Department of Pathology, Sir Run Run Shaw Hospital Affiliated with Zhejiang University School of Medicine, Hangzhou, 310000, China.
Jiang Y; Department of Pathology, Sir Run Run Shaw Hospital Affiliated with Zhejiang University School of Medicine, Hangzhou, 310000, China. .
Pokaż więcej
Źródło:
BMC immunology [BMC Immunol] 2024 Feb 09; Vol. 25 (1), pp. 15. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Crohn Disease*
Intraepithelial Lymphocytes*/metabolism
Humans ; Granzymes ; Perforin ; T-Lymphocytes, Cytotoxic ; Intestinal Mucosa ; HLA-DR Antigens ; Receptors, Antigen, T-Cell, gamma-delta/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinicopathological features of graft versus host disease-associated myositis.
Autorzy:
Kazuta T; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Department of Neurology, Chutoen General Medical Center, Kakegawa, Japan.
Murakami A; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; National Hospital Organization Suzuka National Hospital, Suzuka, Japan.
Noda S; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; National Hospital Organization Suzuka National Hospital, Suzuka, Japan.
Hirano S; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; National Hospital Organization Suzuka National Hospital, Suzuka, Japan.
Kito H; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; National Hospital Organization Suzuka National Hospital, Suzuka, Japan.
Tsujikawa K; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nakanishi H; Department of Neurology, Yokkaichi Municipal Hospital, Yokkaichi, Japan.
Kimura S; National Hospital Organization Suzuka National Hospital, Suzuka, Japan.
Sahashi K; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Koike H; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Division of Neurology, Department of Internal Medicine, Saga University Faculty of Medicine, Saga, Japan.
Katsuno M; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Department of Clinical Research Education, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Pokaż więcej
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Feb; Vol. 11 (2), pp. 508-519. Date of Electronic Publication: 2023 Dec 28.
Typ publikacji:
Review; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Myositis*/etiology
Myositis*/diagnosis
Graft vs Host Disease*/complications
Humans ; Retrospective Studies ; Programmed Cell Death 1 Receptor ; HLA-DR Antigens/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association between Plasma HLA-DR+ Placental Vesicles and Preeclampsia: A Pilot Longitudinal Cohort Study.
Autorzy:
Onori M; Faculty of Medicine and Surgery, Catholic University of the Sacred Heart, L.go F.Vito 1, 00168 Rome, Italy.
Franco R; Faculty of Medicine and Surgery, Catholic University of the Sacred Heart, L.go F.Vito 1, 00168 Rome, Italy.
Lucchetti D; Faculty of Medicine and Surgery, Catholic University of the Sacred Heart, L.go F.Vito 1, 00168 Rome, Italy.
Tartaglia S; Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A.Gemelli 8, 00168 Rome, Italy.
Buongiorno S; Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A.Gemelli 8, 00168 Rome, Italy.
Beneduce G; Faculty of Medicine and Surgery, Catholic University of the Sacred Heart, L.go F.Vito 1, 00168 Rome, Italy.
Sannino F; Faculty of Medicine and Surgery, Catholic University of the Sacred Heart, L.go F.Vito 1, 00168 Rome, Italy.
Baroni S; Faculty of Medicine and Surgery, Catholic University of the Sacred Heart, L.go F.Vito 1, 00168 Rome, Italy.; Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A.Gemelli 8, 00168 Rome, Italy.
Urbani A; Faculty of Medicine and Surgery, Catholic University of the Sacred Heart, L.go F.Vito 1, 00168 Rome, Italy.; Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A.Gemelli 8, 00168 Rome, Italy.
Lanzone A; Faculty of Medicine and Surgery, Catholic University of the Sacred Heart, L.go F.Vito 1, 00168 Rome, Italy.; Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A.Gemelli 8, 00168 Rome, Italy.
Scambia G; Faculty of Medicine and Surgery, Catholic University of the Sacred Heart, L.go F.Vito 1, 00168 Rome, Italy.; Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A.Gemelli 8, 00168 Rome, Italy.
Di Simone N; Department of Biomedical Sciences, Humanitas University, 20072 Milan, Italy.; IRCCS Humanitas Research Hospital, 20089 Milan, Italy.
Tersigni C; Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A.Gemelli 8, 00168 Rome, Italy.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Jan 20; Vol. 13 (2). Date of Electronic Publication: 2024 Jan 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Placenta*/metabolism
Pre-Eclampsia*/metabolism
Humans ; Female ; Pregnancy ; Longitudinal Studies ; HLA-DR Antigens/metabolism ; Placentation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Expression of HLA-DR by mesenchymal stromal cells in the platelet lysate era: an obsolete release criterion for MSCs?
Autorzy:
Kuçi Z; Department for Children and Adolescents, Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Goethe University Frankfurt, University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Piede N; Department for Children and Adolescents, Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Goethe University Frankfurt, University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Vogelsang K; Department for Children and Adolescents, Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Goethe University Frankfurt, University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Pfeffermann LM; Institute for Transfusion Medicine and Immunohematology, Goethe University and German Red Cross Blood Service BaWüHe, Institute Frankfurt, Frankfurt, Germany.
Wehner S; Department for Children and Adolescents, Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Goethe University Frankfurt, University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Salzmann-Manrique E; Department for Children and Adolescents, Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Goethe University Frankfurt, University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Stais M; Department for Children and Adolescents, Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Goethe University Frankfurt, University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Kreyenberg H; Department for Children and Adolescents, Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Goethe University Frankfurt, University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Bonig H; Institute for Transfusion Medicine and Immunohematology, Goethe University and German Red Cross Blood Service BaWüHe, Institute Frankfurt, Frankfurt, Germany.
Bader P; Department for Children and Adolescents, Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Goethe University Frankfurt, University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Kuçi S; Department for Children and Adolescents, Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Goethe University Frankfurt, University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Jan 09; Vol. 22 (1), pp. 39. Date of Electronic Publication: 2024 Jan 09.
Typ publikacji:
Journal Article
MeSH Terms:
Transforming Growth Factor beta1*
Mesenchymal Stem Cells*
Humans ; Leukocytes, Mononuclear ; HLA-DR Antigens ; Histocompatibility Antigens Class II
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An integrative model with HLA-DR, CD64, and PD-1 for the diagnostic and prognostic evaluation of sepsis.
Autorzy:
Chen G; State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Surgery Research, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.; Department of Emergency, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Chong H; State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Surgery Research, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Zhang P; Yubei District Hospital of TCM, Chongqing, China.
Wen D; State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Surgery Research, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Du J; State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Surgery Research, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Gao C; State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Surgery Research, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Zeng S; Department of Neurosurgery, The People's Hospital of Chongqing Banan District, Chongqing, China.
Zeng L; State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Surgery Research, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Deng J; State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Surgery Research, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.; Department of Emergency, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Zhang K; State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Surgery Research, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Zhang A; State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Surgery Research, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Pokaż więcej
Źródło:
Immunity, inflammation and disease [Immun Inflamm Dis] 2024 Jan; Vol. 12 (1), pp. e1138.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Programmed Cell Death 1 Receptor*
Sepsis*/diagnosis
Humans ; Prognosis ; Case-Control Studies ; Critical Illness ; HLA-DR Antigens
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tumor necrosis factor α, and agonist and antagonists of cannabinoid receptor type 1 and type 2 alter the immunophenotype of stem cells from human exfoliated deciduous teeth.
Autorzy:
Trevizani M; Instituto de Ciências Biológicas , Universidade Federal de Juiz de Fora , Juiz de Fora , MG , Brazil .
Leal LL; Instituto de Ciências Biológicas , Universidade Federal de Juiz de Fora , Juiz de Fora , MG , Brazil .
Rettore JVP; Instituto de Ciências Biológicas , Universidade Federal de Juiz de Fora , Juiz de Fora , MG , Brazil .
Macedo GC; Instituto de Ciências Biológicas , Universidade Federal de Juiz de Fora , Juiz de Fora , MG , Brazil .
Alves CCS; Faculdade de Medicina do Mucuri , Universidade Federal dos Vales do Jequitinhonha e Mucuri , Teófilo Otoni , MG , Brazil .
Castro SBR; Faculdade de Medicina do Mucuri , Universidade Federal dos Vales do Jequitinhonha e Mucuri , Teófilo Otoni , MG , Brazil .
Carmo AMRD; Instituto de Ciências Biológicas , Universidade Federal de Juiz de Fora , Juiz de Fora , MG , Brazil .
Silva SAD; Instituto de Ciências Biológicas , Universidade Federal de Juiz de Fora , Juiz de Fora , MG , Brazil .
Maranduba CMDC; Instituto de Ciências Biológicas , Universidade Federal de Juiz de Fora , Juiz de Fora , MG , Brazil .
Silva FS; Universidade Federal de Juiz de Fora , Governador Valadares , MG , Brazil .
Pokaż więcej
Źródło:
Einstein (Sao Paulo, Brazil) [Einstein (Sao Paulo)] 2023 Nov 13; Vol. 21, pp. eAO0405. Date of Electronic Publication: 2023 Nov 13 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
B7-H1 Antigen*/metabolism
B7-H1 Antigen*/pharmacology
Tumor Necrosis Factor-alpha*
Humans ; Cell Differentiation/physiology ; Cells, Cultured ; Endocannabinoids/pharmacology ; Endocannabinoids/metabolism ; HLA-DR Antigens/metabolism ; HLA-DR Antigens/pharmacology ; Receptors, Cannabinoid/metabolism ; Stem Cells/metabolism ; Tooth, Deciduous
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Monocyte CD14 and HLA-DR expression increases with disease duration and severity in amyotrophic lateral sclerosis.
Autorzy:
Mcgill RB; School of Biomedical Sciences, The University of Queensland, Brisbane, Australia.
Steyn FJ; School of Biomedical Sciences, The University of Queensland, Brisbane, Australia.; Wesley Medical Research, The Wesley Hospital, Brisbane, Australia.; University of Queensland Centre for Clinical Research, The University of Queensland, Brisbane, Australia.; Department of Neurology, Royal Brisbane & Women's Hospital, Brisbane, Australia.
Ngo ST; Wesley Medical Research, The Wesley Hospital, Brisbane, Australia.; University of Queensland Centre for Clinical Research, The University of Queensland, Brisbane, Australia.; Department of Neurology, Royal Brisbane & Women's Hospital, Brisbane, Australia.; Queensland Brain Institute, The University of Queensland, Brisbane, Australia, and.; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Australia.
Thorpe KA; Department of Neurology, Royal Brisbane & Women's Hospital, Brisbane, Australia.
Heggie S; Department of Neurology, Royal Brisbane & Women's Hospital, Brisbane, Australia.
Henderson RD; University of Queensland Centre for Clinical Research, The University of Queensland, Brisbane, Australia.; Department of Neurology, Royal Brisbane & Women's Hospital, Brisbane, Australia.
Mccombe PA; University of Queensland Centre for Clinical Research, The University of Queensland, Brisbane, Australia.; Department of Neurology, Royal Brisbane & Women's Hospital, Brisbane, Australia.
Woodruff TM; School of Biomedical Sciences, The University of Queensland, Brisbane, Australia.; Wesley Medical Research, The Wesley Hospital, Brisbane, Australia.; Queensland Brain Institute, The University of Queensland, Brisbane, Australia, and.
Pokaż więcej
Źródło:
Amyotrophic lateral sclerosis & frontotemporal degeneration [Amyotroph Lateral Scler Frontotemporal Degener] 2022 Aug; Vol. 23 (5-6), pp. 430-437. Date of Electronic Publication: 2021 Aug 16.
Typ publikacji:
Journal Article
MeSH Terms:
Amyotrophic Lateral Sclerosis*/genetics
Amyotrophic Lateral Sclerosis*/metabolism
HLA-DR Antigens*/metabolism
Lipopolysaccharide Receptors*/metabolism
Monocytes*/metabolism
Biomarkers/metabolism ; Flow Cytometry ; Humans ; Longitudinal Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Causal role of immune cells in alopecia areata: A two-sample Mendelian randomization study.
Autorzy:
Xu W; School of Medicine, Zhejiang University, Hangzhou, China.; Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou, China.
Shen Y; Hangzhou Third Hospital, Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.
Sun J; Hangzhou Third Hospital, Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.
Wei D; School of Medicine, Zhejiang University, Hangzhou, China.; Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou, China.
Xie B; Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou, China.
Song X; Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou, China.
Pokaż więcej
Źródło:
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) [Skin Res Technol] 2024 Jan; Vol. 30 (1), pp. e13579.
Typ publikacji:
Journal Article
MeSH Terms:
Alopecia Areata*
Humans ; Mendelian Randomization Analysis ; Risk Factors ; HLA-DR Antigens
SCR Disease Name:
Diffuse alopecia
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Nickel Challenge In Vitro Affects CD38 and HLA-DR Expression in T Cell Subpopulations from the Blood of Patients with Nickel Allergy.
Autorzy:
Artuc M; Department of Dermatology and Allergy, Allergy Center Charité, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Zuberbier T; Berlin Institute of Allergology, Charité-Universitätsmedizin, Campus Benjamin Franklin, 12203 Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, 12203 Berlin, Germany.
Peiser M; Institute for Chemistry and Biochemistry, Free University Berlin, 14195 Berlin, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 25; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 25.
Typ publikacji:
Journal Article
MeSH Terms:
Nickel*/adverse effects
Hypersensitivity*
Humans ; Receptors, CCR7 ; HLA-DR Antigens
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Bioinformatics analysis of hub genes as osteoarthritis prognostic biomarkers.
Autorzy:
Zeng J; Department of Orthopedics, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 17, Yongwaizheng Street, Donghu District, Nanchang City, Jiangxi Province, 330000, People's Republic of China.
Jiang X; Department of Orthopedics, Yugan County Hospital, No. 1, Mianshan Avenue, Yugan County, Shangrao City, Jiangxi Province, 335100, People's Republic of China.
Jiang M; Department of Orthopedics 10th, The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, No. 445, Bayi Avenue, Donghu District, Nanchang City, Jiangxi Province, 330000, People's Republic of China.
Cao Y; Department of Orthopedics, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 17, Yongwaizheng Street, Donghu District, Nanchang City, Jiangxi Province, 330000, People's Republic of China.
Jiang Y; Department of Orthopedics, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 17, Yongwaizheng Street, Donghu District, Nanchang City, Jiangxi Province, 330000, People's Republic of China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Dec 21; Vol. 13 (1), pp. 22894. Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Regulatory Networks*
Osteoarthritis, Knee*
Humans ; Aged ; Animals ; Rats ; Prognosis ; HLA-DR alpha-Chains ; Computational Biology ; Biomarkers ; Gene Expression Profiling
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An immunoinformatics study reveals a new BoLA-DR-restricted CD4+ T cell epitopes on the Gag protein of bovine leukemia virus.
Autorzy:
Pluta A; Department of Biochemistry, National Veterinary Research Institute, 24-100, Puławy, Poland. .
Taxis TM; Department of Animal Science, College of Agriculture and Natural Resources, Michigan State University, East Lansing, MI, 48824, USA.
van der Meer F; Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada.
Shrestha S; Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada.
Qualley D; Department of Chemistry and Biochemistry, and Center for One Health Studies, Berry College, Mt. Berry, GA, 30149, USA.
Coussens P; Department of Animal Science, College of Agriculture and Natural Resources, Michigan State University, East Lansing, MI, 48824, USA.
Rola-Łuszczak M; Department of Biochemistry, National Veterinary Research Institute, 24-100, Puławy, Poland.
Ryło A; Department of Biochemistry, National Veterinary Research Institute, 24-100, Puławy, Poland.
Sakhawat A; Animal Quarantine Department, Ministry of National Food Security and Research, Peshawar, 25000, Pakistan.
Mamanova S; Laboratory of Virology, Kazakh Scientific Research Veterinary Institute, LLP, 223 Raiymbek Avenue, 050000, Almaty, Republic of Kazakhstan.
Kuźmak J; Department of Biochemistry, National Veterinary Research Institute, 24-100, Puławy, Poland.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Dec 15; Vol. 13 (1), pp. 22356. Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:
Journal Article
MeSH Terms:
CD4-Positive T-Lymphocytes*
Leukemia Virus, Bovine*/genetics
Animals ; Cattle ; Epitopes, T-Lymphocyte/genetics ; Gene Products, gag/genetics ; Leukocytes, Mononuclear ; HLA-DR Antigens ; Peptides
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Aberrant expression of T cell activation markers and upregulation of Tregs in bone marrow and peripheral blood in acute myeloid leukemia patients.
Autorzy:
Fang J; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.; Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.; Cellular and Molecular Diagnostics Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
Zhang R; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.; Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
Lin X; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.; Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
Xu Y; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.; Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
Huang K; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.; Department of Hematology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
Saw PE; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.; Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2219554.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Marrow*/pathology
Leukemia, Myeloid, Acute*/pathology
Humans ; CD8-Positive T-Lymphocytes/pathology ; Up-Regulation ; HLA-DR Antigens/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Potential biomarkers for fatal outcome prognosis in a cohort of hospitalized COVID-19 patients with pre-existing comorbidities.
Autorzy:
Madera-Sandoval RL; Unidad de Investigación Médica en Inmunoquímica, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Cérbulo-Vázquez A; Servicio de Medicina Genómica, Hospital General de México, Ciudad de México, Mexico.
Arriaga-Pizano LA; Unidad de Investigación Médica en Inmunoquímica, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Cabrera-Rivera GL; Unidad de Investigación Médica en Inmunoquímica, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.; Posgrado en Inmunología, Instituto Politécnico Nacional, Ciudad de México, Mexico.
Basilio-Gálvez E; Unidad de Investigación Médica en Inmunoquímica, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.; Posgrado de Ciencias Químicobiológicas, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México, Mexico.
Miranda-Cruz PE; Unidad de Investigación Médica en Inmunoquímica, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
García de la Rosa MT; Unidad de Investigación Médica en Inmunoquímica, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.; Posgrado en Inmunología, Instituto Politécnico Nacional, Ciudad de México, Mexico.
Prieto-Chávez JL; Centro de Instrumentos, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Rivero-Arredondo SV; Unidad de Investigación Médica en Inmunoquímica, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Cruz-Cruz A; Unidad de Investigación Médica en Inmunoquímica, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Rodríguez-Hernández D; Unidad de Investigación Médica en Inmunoquímica, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Salazar-Ríos ME; Unidad de Investigación Médica en Inmunoquímica, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Salazar-Ríos E; Unidad de Investigación Médica en Inmunoquímica, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Serrano-Molina ED; Unidad de Investigación Médica en Inmunoquímica, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
De Lira-Barraza RC; Medicina Interna, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Villanueva-Compean AH; Medicina Interna, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Esquivel-Pineda A; Medicina Interna, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Ramírez-Montes de Oca R; Medicina Interna, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Unzueta-Marta O; Medicina Interna, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Flores-Padilla G; Medicina Interna, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Anda-Garay JC; Medicina Interna, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Sánchez-Hurtado LA; Unidad de Cuidados Intensivos, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Calleja-Alarcón S; Unidad de Cuidados Intensivos, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Romero-Gutiérrez L; Unidad de Cuidados Intensivos, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Torres-Rosas R; Laboratorio de Inmunología, Centro de Estudios en Ciencias de la Salud y la Enfermedad, Facultad de Odontología, Universidad Autónoma 'Benito Juárez' de Oaxaca (UABJO), Oaxaca de Juárez, Mexico.
Bonifaz LC; Unidad de Investigación Médica en Inmunoquímica, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.; Coordinación de Investigación en Salud, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México, Mexico.
Pelayo R; Centro de Investigación Biomédica de Oriente, IMSS, Puebla, Mexico.; Unidad de Educación e Investigación, IMSS, Ciudad de México, Mexico.
Márquez-Márquez E; Servicio de Medicina Genómica, Hospital General de México, Ciudad de México, Mexico.
López-Macías CIIIR; Unidad de Investigación Médica en Inmunoquímica, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Ferat-Osorio E; Coordinación de Investigación en Salud, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México, Mexico.; División de Investigación en Salud, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, Mexico.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2023 Dec; Vol. 16 (12), pp. 2687-2699. Date of Electronic Publication: 2023 Nov 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/complications
Humans ; Prospective Studies ; Interleukin-6 ; Pandemics ; Prognosis ; Biomarkers ; Neutrophils ; HLA-DR Antigens ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 6782

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies